Emerg Infect Dis by V\ue4is\ue4nen, Elina et al.
LETTERS
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	20,	No.	6,	June	2014	 1077
This study was supported by 
the National Major S & T Project 
(2012ZX10004-206), the International 
Science and Technology Cooperation 
Program of China (2010DFB33270), 
China National Funds for Distinguished 
Young Scientists (81225014), Program 
for Changjiang Scholars and Innovative 
Research Team in University (IRT13007), 
and Fondation Mérieux.
Zichun Xiang,1  
Sosorbaramyn Tsatsral,1 
Chunyan Liu,1 Linlin Li, Lili Ren, 
Yan Xiao, Zhengde Xie,  
Hongli Zhou, Guy Vernet, 
Pagbajabyn Nymadawa, 
Kunling Shen,  
and Jianwei Wang
Author	 affiliations:	 MOH	 Key	 Laboratory	
of	Systems	Biology	of	Pathogens,	Beijing,	
China;	 (Z.	Xiang,	 L.	 Li,	 L.	Ren,	 J.	Wang);	
Institute	 of	 Pathogen	 Biology,	 Beijing	 (Z.	
Xiang,	 L.	 Li,	 L.	 Ren,	Y.	 Xiao,	 H.	 Zhou,	 J.	
Wang);	 National	 Center	 of	 Communica-
ble	 Diseases,	 Ulaanbaatar,	 Mongolia	 (S.	
Tsatsral,	P.	Nymadawa);	Beijing	Children’s	
Hospital	 Affiliated	 to	 Capital	 Medical	 Uni-




Address for correspondence: Jianwei Wang, 9# 
Dong Dan San Tiao, Dongcheng District, Beijing 
100730, China; email: wangjw28@163.com
DOI:	http://dx.doi.org/10.3201/eid2006.131596
References
  1. Pallansch M, Roos R. Enteroviruses: 
polioviruses, coxsackieviruses, echo-
viruses, and newer enteroviruses. In: 
Knipe DM, Howley PM, editors. Field’s 
virology. 5th ed. Philadelphia: Lippincott 
Williams & Wilkins; 2007.
  2. Daleno C, Piralla A, Scala A, Baldanti F, 
Usonis V, Principi N, et al. Complete 
genome sequence of a novel human 
enterovirus C (HEV-C117) identified 
in a child with community-acquired 
pneumonia. J Virol. 2012;86:10888–9. 
http://dx.doi.org/10.1128/JVI.01721-12
  3. Daleno C, Piralla A, Usonis V, Scala A, 
Ivaskevicius R, Baldanti F, et al. Novel 
human enterovirus C infection in child 
with community-acquired pneumonia. 
Emerg Infect Dis. 2012;18:1913–5. 
http://dx.doi.org/10.3201/eid1811.120321
  4. Xiang Z, Xie Z, Wang Z, Ren L, Xiao Y, 
Li L, et al. Human enterovirus geno-
type 104 infection in China. Emerg 
Infect Dis. 2013;19:689–91. http://dx.doi.
org/10.3201/eid1904.121435
  5. Nix WA, Oberste MS, Pallansch MA. 
Sensitive, seminested PCR amplifica-
tion of VP1 sequences for direct iden-
tification of all enterovirus serotypes 
from original clinical specimens. J Clin 
Microbiol. 2006;44:2698–704. http://dx. 
doi.org/10.1128/JCM.00542-06
  6. Savolainen C, Blomqvist S, Mulders MN, 
Hovi T. Genetic clustering of all 102 
human rhinovirus prototype strains: 
serotype 87 is close to human enterovirus 
70. J Gen Virol. 2002;83:333–40.
  7. Lee WM, Kiesner C, Pappas T, Lee I, 
Grindle K, Jartti T, et al. A diverse group 
of previously unrecognized human rhi-
noviruses are common causes of respi-
ratory illnesses in infants. PLoS ONE. 
2007;2:e966. http://dx.doi.org/10.1371/
journal.pone.0000966
  8. Briese T, Renwick N, Venter M, 
Jarman RG, Ghosh D, Köndgen S, et al. 
Global distribution of novel rhinovirus gen-
otype. Emerg Infect Dis. 2008;14:944–7. 
http://dx.doi.org/10.3201/eid1406.080271
  9. Tapparel C, Junier T, Gerlach D, 
Van-Belle S, Turin L, Cordey S, et al. New 
respiratory enterovirus and recombinant 
rhinoviruses among circulating picornavi-
ruses. Emerg Infect Dis. 2009;15:719–26. 
http://dx.doi.org/10.3201/eid1505.081286
Address for correspondence: Jianwei Wang, 
Institute of Pathogen Biology, Chinese Academy 
of Medical Sciences, MOH Key Laboratory of 
Systems Biology of Pathogens and Christophe 
Mérieux Laboratory, IPB, CAMS-Fondation 
Mérieux, Institute of Pathogen Biology 
(IPB), Chinese Academy of Medical Sciences 
(CAMS), 9# Dong Dan San Tiao, Beijing 
100730, China; email: wangjw28@163.com
Bufavirus in Feces 
of Patients with 
Gastroenteritis, 
Finland
To the Editor: For nearly 3 de-
cades, human parvovirus B19 (B19V) 
was considered to be the only patho-
genic parvovirus found in humans. 
Since 2005, several new human par-
voviruses have been found, including 
human bocaviruses 1–4 and human 
parvovirus 4 (PARV4) (1–5), and dur-
ing 2012, metagenomic analysis of fe-
cal samples from children in Burkina 
Faso with acute diarrhea showed a 
highly divergent parvovirus, which 
was named bufavirus (BuV) (6). Its 
sequence in the coding region showed 
<31% similarity with known parvo-
viruses, the closest genera being Pro-
toparvovirus and Amdoparvovirus. 
Subsequent studies, on the basis of 
PCR results, showed that 4% of fe-
cal samples from Burkina Faso (n = 
98) and 1.6% from Tunisia (n = 63) 
harbored either of 2 genotypes of this 
new virus, which belongs to the spe-
cies Primate protoparvovirus 1 of the 
genus Protoparvovirus (6,7; http://ict-
vonline.org).
To assess the occurrence of BuV 
in northern Europe, we analyzed 629 
fecal samples from patients of all 
ages (median 51.5 years, range 0–99) 
in Finland who had gastroenteritis. 
To gain a more complete representa-
tion of BuV occurrence, we obtained 
samples retrospectively from routine 
diagnostics for bacterial and viral 
gastroenteritis-inducing pathogens 
(HUSLAB, Helsinki University Cen-
tral Hospital Laboratory Division, 
Helsinki, Finland) and analyzed all 
samples available during the collec-
tion periods.
The samples originally sent to 
HUSLAB for bacterial diagnosis 
(bacterial cohort, n = 243) had been 
analyzed during October 2012–March 
2013 for Salmonella spp., Shigella 
spp., Campylobacter spp., Yersinia 




spp., Vibrio cholerae, and Escherichia 
coli (subtypes enterohemorraghica, 
enteropatogena, enterotoxigenic and 
enteroagregativa) by using culture or 
PCR (8). In 81 (33.3%) of the sam-
ples, >1 bacterial pathogen was found. 
The samples originally sent for 
viral diagnosis (viral cohort, n = 
386) had been tested in HUSLAB 
for norovirus during April–May, 
2013 by using reverse transcription 
quantitative PCR (RT-qPCR)(HUS-
LAB in-house). Further diagnosis for 
rotavirus and adenovirus had been 
requested by physicians from 105 
(27.2%) of 386 samples (Diarlex MB 
antigen detection assay, Orion Di-
agnostica, Espoo, Finland), and for 
astrovirus from 33 (8.6%) samples 
(RT-PCR, HUSLAB in-house). A vi-
ral pathogen was discovered in 141 
(36.5%) samples; in 139, the patho-
gen was norovirus.
The samples had been sent from 
diverse locations within Finland, and 
thus were not from a few isolated 
outbreaks. No further information 
on patients and samples was avail-
able for either cohort, and not enough 
samples were left for retrospective 
analysis of additional pathogens. The 
Ethics Committee of the Hospital 
District of Helsinki and Uusimaa ap-
proved the study.
BuV DNA was detected by us-
ing a new real-time qPCR with the 
following primers and probe: BuV 
forward, 5′-ACAGTGTAGACAGTG-
GATTCAAACTT-3′; BuV reverse, 
5′-GTTGTGGTTGGATTGTGGT-
TAGTTC-3′; BuV qPCR probe, 
5′-FAM-CGGAAGAGATTTTGA-
CAGTGCYTAGCAA-BHQ1 3′ . 
The detailed qPCR protocol is shown 
in the online Technical Appendix 
(wwwnc.cdc.gov/EID/article/20/6/13-
1674-Techapp1.pdf). The analytical 
sensitivity of the RT-qPCR assay was 
5–10 copies per reaction.
Of the 629 fecal samples, 7 (1.1%) 
were positive for BuV DNA, of which 
4 were from the bacterial cohort and 3 
from the viral cohort. BuV DNA quan-
tity was low in all samples, ranging 
from 1.9 × 103 to 3.2 × 104 copies per 
milliliter of fecal supernatant (Table). 
In contrast to the original discovery of 
the virus in children with diarrhea (6), 
all positive samples were from adults 
(median age 53 years, range 21–89 
years). All BuV DNA–positive re-
sults were confirmed by repeated BuV 
qPCR, by amplifying and sequencing 
another area of the virus, or by both 
methods (Table): all sequenced am-
plicons were more similar to the BuV 
genotype 1 (online Technical Appen-
dix Figure) (6). Two of the BuV-pos-
itive samples were from the same pa-
tient, taken 4 days apart, and the latter 
sample also harbored norovirus. The 
additional 6 BuV-positive samples 
were negative for the other viral or 
bacterial pathogens tested.
Seven fecal samples collected 
from adults in Finland contained 
BuV DNA, indicating that circula-
tion of the virus is restricted neither 
to children nor to Africa. However, 
the low DNA loads in all the positive 
samples suggest that BuV might not 
be the primary cause of these cases 
of gastroenteritis. A known gastroen-
teritis-inducing pathogen (norovirus) 
was found in 1 of the 7 BuV-positive 
samples. We did not observe any 
clustering of the 7 positive samples 
into a specific period (Table).
Although the association with 
gastroenteritis seems weak, BuV 
might cause symptoms of other types. 
We did not include feces from healthy 
subjects for comparison. The identi-
fied BuV DNA in our samples could 
originate from previous or current in-
fections unrelated to gastroenteritis, or 
be associated with prolonged virus se-
cretion in the respiratory or digestive 
tracts, a phenomenon shown, e.g., for 
human bocavirus1 (9,10). Acquisition 
of the virus from a food source can-
not be ruled out, although 1 patient 
harbored the DNA for at least 4 days, 
during which a 10-fold increase in vi-
ral load was observed.
Overall, this study shows that BuV 
circulates in northern Europe and can 


















1 Bacterial 5.2	 103 21/M Bacteria 0 2012	Dec	4 VP2,	2786–4495,	0.88 
2 Bacterial 1.9	104 38/M Bacteria 0 2013	Jan	6 VP2,	2786–4495,	0.71 
3§ Bacterial 1.9	 103 53/M Bacteria 0 2013	Jan	11 § 
4 Bacterial 3.7	 103 46/M Bacteria 0 2013	Apr	27 VP2,	2786–4495,	0.76 
5 Viral 3.4	 103 77/M Norovirus 0 2013	Apr	19 VP2,	2786–4495,	1.60 
6¶ Viral 3.6	 103 89/F Norovirus 0 2013	Apr	20 Partial	NS,	16–1080,	1.13 
7¶ Viral 3.2	 104 89/F Norovirus Norovirus 2013	Apr	23 VP2,	2786–4495,	1.36 
*VP2,	viral	protein	2;	NS,	nonstructural. 
†Samples originally sent to HUSLAB (Helsinki, Finland) for bacterial diagnosis were analyzed for Salmonella spp.,	Shigella spp.,	Campylobacter spp.,	











gastroenteritis. Despite the absence of 
known pathogens among 6 of 7 BuVs-
shedding patients, the causative role of 
BuV in gastroenteritis remains uncer-
tain. Serologic studies will help clarify 
a possible association between BuVs 
and diarrhea or other diseases.
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Acquired in  
Scotland, 2013
To the Editor: Human granu-
locytic anaplasmosis is a tick-borne 
disease caused by Anaplasma phago-
cytophilum, an obligate intracellular 
gram-negative bacterium that infects 
granulocytes. The usual clinical signs 
and symptoms include nonspecific 
fever, chills, headache, and myalgia. 
Infection is usually mild or asymp-
tomatic, but severe systemic compli-
cations can occur, leading to a need for 
intensive care and estimated fatality 
rates of 0.5%–1.0% (1,2).
A. phagocytophilum was first 
described in 1932 in Scotland as the 
causative agent of tick-borne fever in 
sheep (3). Although some clinical cases 
of human granulocytic anaplasmosis 
have been reported in Europe, mostly 
from Slovenia, Sweden, and Poland 
(4), most cases have occurred in the 
United States. This difference cannot 
be explained by the prevalence of the 
pathogen in ticks or human exposure 
to the pathogen because the 3% preva-
lence of A. phagocytophilum among 
Ixodes ricinus ticks in Europe seems to 
be nearly as high as that among ticks in 
the United States (2). The median se-
roprevalence rate for A. phagocytophi-
lum infection among humans in Europe 
is 6.2%, reaching up to 21% (2). This 
incongruence between seroprevalence 
rate and number of human cases might 
be associated with underdiagnosis of 
cases (2), a high rate of asymptomatic 
disease (5), or cross-reactivities in se-
rologic tests that might lead to overesti-
mation of seroprevalence rate (5).
In August 2013, an immuno-
competent 40-year-old man sought 
treatment for fever (≈39°C) and other 
nonspecific symptoms such as mal-
aise, myalgia, and severe headache 3 
days after becoming aware of several 
tick bites received while on a hiking 
